OMNIAB, INC. Increase (Decrease) in Other Noncurrent Assets
OMNIAB, INC. (OABI) reported Increase (Decrease) in Other Noncurrent Assets of -$211.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-06
- OMNIAB, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$94.00K.
- OMNIAB, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$117.00K.
- OMNIAB, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$116.00K.
- OMNIAB, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$138.00K.
- OMNIAB, INC. increase (decrease) in other noncurrent assets for fiscal 2025 was -$628.00K.
- OMNIAB, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was -$645.00K.
- OMNIAB, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was -$642.00K, a 181.47% decline from fiscal 2022.
- OMNIAB, INC. increase (decrease) in other noncurrent assets for fiscal 2022 was $788.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$211.00K 10-Q · filed 2026-08-06 | -$327.00K derived: sum of 3 quarters · filed 2026-08-06 | -$465.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$117.00K 10-Q · filed 2026-05-07 | -$233.00K derived: sum of 2 quarters · filed 2026-05-07 | -$371.00K derived: sum of 3 quarters · filed 2026-05-07 | -$487.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$254.00K derived: sum of 2 quarters · filed 2026-03-04 | -$370.00K derived: sum of 3 quarters · filed 2026-08-06 | -$628.00K 10-K · filed 2026-03-04 |
| 2025-09-30 | -$138.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$254.00K derived: sum of 2 quarters · filed 2026-08-06 | -$512.00K 10-Q · filed 2025-11-04 | -$593.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$116.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$374.00K 10-Q · filed 2026-08-06 | -$455.00K derived: sum of 3 quarters · filed 2026-08-06 | -$541.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$258.00K 10-Q · filed 2026-05-07 | -$339.00K derived: sum of 2 quarters · filed 2026-05-07 | -$425.00K derived: sum of 3 quarters · filed 2026-05-07 | -$644.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$167.00K derived: sum of 2 quarters · filed 2026-03-04 | -$386.00K derived: sum of 3 quarters · filed 2026-03-04 | -$645.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | -$86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$305.00K derived: sum of 2 quarters · filed 2025-11-04 | -$564.00K 10-Q · filed 2025-11-04 | -$1.34M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$219.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$478.00K 10-Q · filed 2025-08-06 | -$1.25M derived: sum of 3 quarters · filed 2025-08-06 | -$1.42M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$259.00K 10-Q · filed 2025-05-08 | -$1.03M derived: sum of 2 quarters · filed 2025-05-08 | -$1.20M derived: sum of 3 quarters · filed 2025-05-08 | -$795.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$776.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$944.00K derived: sum of 2 quarters · filed 2025-03-18 | -$536.00K derived: sum of 3 quarters · filed 2025-03-18 | -$642.00K 10-K · filed 2025-03-18 |
| 2023-09-30 | -$168.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $240.00K derived: sum of 2 quarters · filed 2024-11-12 | $134.00K 10-Q · filed 2024-11-12 | $2.68M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $408.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $302.00K 10-Q · filed 2024-08-08 | $2.85M derived: sum of 3 quarters · filed 2024-08-08 | $2.85M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$106.00K 10-Q · filed 2024-05-09 | $2.44M derived: sum of 2 quarters · filed 2024-05-09 | $2.44M derived: sum of 3 quarters · filed 2024-05-09 | $775.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $2.54M derived: sum of 2 quarters · filed 2024-03-25 | $881.00K derived: sum of 3 quarters · filed 2024-03-25 | $788.00K 10-K · filed 2024-03-25 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$1.66M derived: sum of 2 quarters · filed 2023-11-09 | -$1.75M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$1.75M 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | -$93.00K 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | -$1.45M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |